Concord Medical Services Holdings Limited (CCM) Comparison with companies in other sectors?

Concord Medical Services Holdings Limited has a share price of 162.14K. You can analyze Concord Medical Services Holdings Limited (CCM) competitors across different market sectors through stock heatmaps.

What are CCM's NET and operating margins?

Concord Medical Services Holdings Limited (CCM) operating margin is around -0.90, and net profit margin is approximately -0.79 as of the latest reports.

In what way does CCM's earnings per share (EPS) trend reflect its financial momentum?

Concord Medical Services Holdings Limited (CCM) EPS is -9.83 (If EPS value is positive, then “signals consistent profit growth” if Negative then “signals consistent loss”). This metric is also critical in assessing valuation metrics like the P/E ratio for Concord Medical Services Holdings Limited is -0.61, and the company’s ability to reinvest or distribute profits.

What does a high ROE mean for Concord Medical Services Holdings Limited?

A high ROE suggests efficient use of shareholder equity to generate profit. It often signals strong management and profitability.

How do I know if AAPL is overvalued or undervalued?

Check valuation ratios for Concord Medical Services Holdings Limited like P/E which is -0.04, P/B which is -0.00, and PEG which is 0.00. Compare them with sector averages to evaluate if the stock is priced fairly.

Concord Medical Services Holdings Limited

CCM•NYSE

Healthcare

Medical - Care Facilities

$5.25

$-0.23(-4.28%)

Fundamental Analysis of Concord Medical Services Holdings Limited (CCM)

Comprehensive financial metrics and ratios analysis

EPS (TTM)

$-9.83

P/E Ratio

-0.61

ROE

0.08%

Net Margin

-0.79%

Key Financial Metrices

Valuation Metrics

4 metrics

Market CapTotal market value of outstanding shares

$967.64K

Shares OutstandingTotal number of shares issued

$162.14K

Book Value/ShareNet worth per share

$370.36

Revenue/ShareAnnual revenue per share

$50.09

Profitability Metrics

6 metrics

EPS (TTM)Earnings per share trailing twelve months

$-9.83

Net MarginNet income as percentage of revenue

-78.72%

Operating MarginOperating income as percentage of revenue

-90.37%

ROEReturn on shareholders' equity

7.88%

ROAReturn on total assets

-2.56%

ROCEReturn on capital employed

-4.30%

Cash Flow Metrics

3 metrics

Free Cash Flow/ShareCash generated per share after capex

Cash/ShareCash and equivalents per share

$80.32

FCF YieldFree cash flow as percentage of market cap

Dividend Metrics

2 metrics

Dividend/ShareAnnual dividend payment per share

Dividend YieldAnnual dividend as percentage of stock price

Financial Ratios Analysis data is not available for CCMFinancial Ratios Analysis details for CCM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Sector Benchmarking data is not available for CCMSector Benchmarking details for CCM are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Understanding Fundamental Analysis for Concord Medical Services Holdings Limited Investment Decisions

What is Fundamental Analysis?

Fundamental analysis is a method used to assess the intrinsic value of Concord Medical Services Holdings Limited. Using financial reports, management structure, competitive position, and market environment, investors can determine whether the stock is undervalued or overvalued. This analysis helps investors like you make more informed investment decisions, taking into account Concord Medical Services Holdings Limited's unique business strengths and challenges.

Key Financial Metrics for Concord Medical Services Holdings Limited

For Concord Medical Services Holdings Limited, essential financial indicators include EPS -9.83, PE -0.61, and ROE 0.08. These key ratios reveal insights into Concord Medical Services Holdings Limited's profitability, valuation, and operational health. Understanding these metrics enables you to compare Concord Medical Services Holdings Limited with its industry peers and decide whether it presents a viable investment opportunity.

Profitability and Operational Efficiency of Concord Medical Services Holdings Limited

Metrics like Net Margin -78.72% and ROA -2.56% shed light on how well Concord Medical Services Holdings Limited is generating profits. A high profitability ratio often indicates strong management and a solid business model, which are essential for long-term growth. These metrics are crucial in assessing whether Concord Medical Services Holdings Limited can sustain its operations and continue growing in the future.

Valuation and Market Position of Concord Medical Services Holdings Limited

Using ratios such as P/B Ratio -0.00 and PEG Ratio 0.00, investors can assess whether Concord Medical Services Holdings Limited is appropriately valued based on its financials and growth potential. These figures, combined with Concord Medical Services Holdings Limited's market capitalization, give insight into its competitive positioning and investor expectations, helping you make informed decisions on pricing and value.

Financial Health and Risk Assessment for Concord Medical Services Holdings Limited

Financial health indicators, such as Debt/Equity Ratio -1.72 and Cash Flow -, provide a snapshot of Concord Medical Services Holdings Limited's ability to meet financial obligations and handle economic setbacks. A company with a strong balance sheet and solid cash flow, like Concord Medical Services Holdings Limited, is more likely to weather financial storms, making it a safer investment.

Long-Term Investment Strategy for Concord Medical Services Holdings Limited

Investing in Concord Medical Services Holdings Limited based on fundamental analysis emphasizes long-term business growth rather than short-term market trends. Investors looking at Concord Medical Services Holdings Limited focus on its solid financial performance, industry standing, and competitive advantages, all of which suggest sustainable growth and the potential for steady returns over time.

Fundamental Analysis FAQ

;